Long COVID is defined as an infection-associated chronic condition that occurs after a symptomatic or asymptomatic SARS-CoV-2 infection and is present for at least three months as a continuous, relapsing and remitting, or progressive disease state that affects one or more organ systems. Anyone who has had a COVID-19 infection, regardless of severity, can develop Long COVID, including children.
Long COVID is a complex problem that requires multidisciplinary solutions. Long COVID care may need to be coordinated through primary care providers and multiple specialists who can help with specific aspects of a patient’s illness, such as cardiologists, neurologists, autoimmune specialists, and rehabilitation providers.
A key component of supporting patients with Long COVID is acknowledging and taking concerns seriously.
As of now there are no peer-reviewed screening tools for Long COVID. However, the Post-COVID-19 Functional Status (PCFS) scale was created to monitor functional limitations over time after COVID-19.
For more information, see the latest Dear Colleague Letter on Long COVID (PDF, September 2024).
Presently, there is no specific treatment recommended for people with Long COVID. Treatment and management plans will need to be patient-centered to address each individual’s symptoms and health conditions. Objective laboratory or imaging findings should not be used as the only measure or assessment of a patient’s well-being. Normal laboratory or imaging findings do not invalidate the existence, severity or importance of a patient’s post-COVID conditions.
For many people, the primary goal in managing Long COVID is to improve daily function and quality of life through well-established symptom management strategies. This includes identifying and addressing the most debilitating symptoms using a patient-centered approach and developing a comprehensive rehabilitation plan.